➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Colorcon
Dow
AstraZeneca
Baxter

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

NOVOLIN R Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: NOVOLIN R
Recent Clinical Trials for NOVOLIN R

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of Illinois at ChicagoPhase 2
State University of New York - Downstate Medical CenterPhase 4
University of California, San FranciscoN/A

See all NOVOLIN R clinical trials

Patent Text Search: US Patents for NOVOLIN R

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
AstraZeneca
Medtronic
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.